logo

Propanc Biopharma Plans to Purchase $100 Million Worth of Ethereum in the Next 12 Months

By: theblockbeats.news|2025/09/02 13:52:27

BlockBeats News, September 2nd, US-listed biopharmaceutical company Propanc Biopharma (PPCB) announced plans to buy $100 million worth of Ethereum in the next 12 months. Propanc Biopharma stated that this move will enhance its overall corporate strategy in various areas such as cryptocurrency investment, drug development, and asset acquisition.

U.S. publicly traded company Empery Digital has announced an additional purchase of 16.51 BTC, increasing its total holdings to 4,081.39 BTC.
Data: Avalon Labs has collected a total of $5.48 million in fees since June.

You may also like

Share
copy

Gainers

Latest Crypto News

14:45

The Federal Reserve's interest rate cut probability in December is close to 90%, and the market will pay close attention to the "dot plot" to speculate on the interest rate trajectory through 2026.

14:45

David Sacks: The baseless accusations from The New York Times lack evidence, and we have retained a defamation law specialist to handle this matter.

14:15

Altura, a blockchain-based yield platform, has completed a $4 million financing round with Ascension as the lead investor.

14:15

In November, the total trading volume of Kalshi and Polymarket approached nearly $10 billion.

13:45

Gleec has acquired Komodo's cross-chain DeFi business for $23.5 million

Read more
Community
icon
icon
icon
icon
icon
icon
icon

Customer Support@weikecs

Business Cooperation@weikecs

Quant Trading & MMbd@weex.com

VIP Servicessupport@weex.com